🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉 A huge thank you to all the #IP5MATTER multicentre Trial Investigators across the UK for their hard work in recruiting over 300 patients from with newly-diagnosed metastatic prostate cancer (NCT04590976) published today in European Urology Oncology European Urology 🔗 authors.elsevier.com/sd/article/S25…

📣Our new ⁦BIR Journals⁩ paper illustrates the importance of creating optimal #SABR plan for lung cancer! #radonc #lcsm ⁦ ⁦⁦Minal Padden-Modi⁩ ⁦⁦Ian Gleeson⁩ ⁦CRUK RadNet Cambridge⁩ Link to full paper 👉 academic.oup.com/bjro/advance-a…

‘Incurable lung cancer could be defeated with breakthrough NHS treatment’ Delighted that the TOURIST trial has been picked up by the national press! I might have phrased the headline differently… ⁦The Christie NHS⁩ ⁦Southampton CTU⁩ telegraph.co.uk/news/2024/09/2…

Are you a trainee interested in lung cancer? Working on a project that you'd like to share with a national MDT audience? Well it's just 8 weeks until BTOG abstract deadline! Details: btog.org/23rd-btog-annu… See you in Belfast 3/5/25-5/5/25!

Delighted to share the results of #PACE B trial, published in NEJM today 5 fraction SBRT is non inferior to CRT! nejm.org/media/doi/full… Alison Tree 💙 Follow us on Bluesky @ICR-CTSU Prof Emma Hall The Royal Marsden NHS Foundation Trust Dr. Andrew Loblaw Clive Peedell ST Prof Joe O'Sullivan Prof Suneil Jain

‼️New article‼️ ✅Clinical utility of an OS AI based auto segmentation ✅Time saved: 36% in prostate & 67% in H&N ✅Anchoring bias varies between structures ✅Most AI segmentation errors corrected by human interaction #radonc #AI Read full paper 👉 clinicaloncologyonline.net/article/S0936-…

📣 New ⁦Clinical Oncology⁩ #OncoFlash is out now! ✅NADINA in melanoma ✅NICHE in colon ca ⁦Myriam Chalabi⁩ ✅MARS-2 in mesothelioma ⁦Eric Lim⁩ ✅RADICALS in prostate ca ⁦Chris Parker⁩ Read here 👉 clinicaloncologyonline.net/article/S0936-…

Pleased to see TOURIST in the paper and the positive experience it can bring to patients express.co.uk/news/uk/201458…

#TOURIST trial is now open in Cambridge University Hospitals NHS, offering an opportunity to pts with lung cancer in Cambridge to participate Southampton CTU Cambridge Cancer Research Hospital CRUK Cambridge Centre: Thoracic Cancer @CRUK RadNet Cambridge CRUK Cambridge Centre

We are delighted to welcome Timothée Olivier, MD from VKPrasadLab to the CRUK Cambridge Institute on 3/3/25 at 17:30 to speak about CDK4/6 Inhibitors and Novel Adjuvant Therapies: Using Statistics to Inform Shared Decision-Making, hosted by CRUK Cambridge Centre: Breast Cancer and Cambridge University Oncology Society.

Join CRUK Cambridge Centre: Breast Cancer at the Breast Cancer Symposium next month for a day of insightful discussions, innovative research, and networking opportunities.  📅 Fri 28 March, 9am-5pm 📍St John’s College, Cambridge Open to all with an interest Register ➡️ zurl.co/LwZn1

#BTOG25 HIT-MESO poster (number 256). Open for recruitment and on target. Ask me or the UCL Cancer Institute clinical trials team if you have any questions. Proton radiotherapy for mesothelioma.

🚨 We're launching the £1.89M #IP13AVIDITY trial to test PSMA PET/CT scans for detecting & escalating #ProstateCancer treatment funded by Prostate Cancer UK Co-led by Hashim U. Ahmed Martin J. Connor #TaraBarwick #RhianGabe #AdamBrentnall The Times and The Sunday Times🗞️⤵️ thetimes.com/uk/healthcare/…

Thank you to The Times and The Sunday Times 📰for covering my first major grant success - the £1.89M #IP13AVIDITY randomised trial testing PSMA PET defined and escalated treatment compared to standard of care for high-risk #prostatecancer Prostate Cancer UK Hashim U. Ahmed thetimes.com/uk/healthcare/…

📣 Join Clinical Lecturer Mr Martin Connor as he presents the first Imperial Prostate randomised controlled trial - #IP2ATLANTA internal pilot results are out! Live on Monday 12:00 ⏱️ #EAU25 🇪🇸 #CytoreductiveSurgery #SABR #Ablation Martin J. Connor Hashim U. Ahmed Wellcome

It’s a big last day at #EAU25 for our team! 🇪🇸 Martin J. Connor - 2x #IP2ATLANTA pilot study results (12:00) Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05) Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)

#IP2-ATLANTA RCT pilot result #EAU25 🇪🇸 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce 🚦Early signal in prostate cancer mortality for cytoreductive arms 📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027! Martin J. Connor

Ready to join Imperial Prostate? We are hunting for the next PhD Clinical Research Fellow for our 13th trial #AVIDITY. PSMA PET/CT only directed treatment in high-risk PCa (closing 15/04). APPLY 🔗: imperial.ac.uk/jobs/search-jo… Imperial Prostate I Hashim U. Ahmed I Imperial College London

Pilot results from #IP2ATLANTA on novel cytoreductive treatments to the prostate & mets in de novo mHSPC presented by Hashim U. Ahmed #AUA25 Take home - these treatments are safe and justified Recruitment for the main trial has completed - PFS endpoint to be reported 2027